Effect of cigarette smoking on serum lipid, lipoprotein and apolipoprotein levels in hypertensives receiving β-adrenoreceptor blocking drugs

Ananthakrishnan Ramani, Sudhakar S. Nayak, A. R. Aroor, G. N. Kundaje

Research output: Contribution to journalArticle

Abstract

Both cigarette smoking and propranolol administration significantly alter plasma lipid profile. We examined the relationship of cigarette smoking and propranolol administration with fasting serum total cholesterol, triglyceride, lipoprotein cholesterol subfractions (high density, low density, and very low density), Apo-A, Apo-B and ratios obtained from these variables in 42 hypertensive patients. Significantly lower values of HDL cholesterol, Apo-A and HDL-C/total cholesterol and Apo-A/Apo-B ratios were observed in smokers taking propranolol than non-smokers not taking propranolol. Smokers who were not on propranolol also had significantly lower values as compared to non-smokers. These findings suggest that smoking may be the more significant factor responsible for alteration in lipid profile.

Original languageEnglish
Pages (from-to)59-64
Number of pages6
JournalIndian Journal of Clinical Biochemistry
Volume6
Issue number1
DOIs
Publication statusPublished - 01-01-1991

Fingerprint

Apolipoproteins
Propranolol
Tobacco Products
Lipoproteins
Apolipoproteins A
Smoking
Lipids
Serum
Pharmaceutical Preparations
Apolipoproteins B
HDL Cholesterol
Cholesterol
Fasting
Triglycerides
Plasmas

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

@article{5e53998fc6654b32a448d1532b91fc4b,
title = "Effect of cigarette smoking on serum lipid, lipoprotein and apolipoprotein levels in hypertensives receiving β-adrenoreceptor blocking drugs",
abstract = "Both cigarette smoking and propranolol administration significantly alter plasma lipid profile. We examined the relationship of cigarette smoking and propranolol administration with fasting serum total cholesterol, triglyceride, lipoprotein cholesterol subfractions (high density, low density, and very low density), Apo-A, Apo-B and ratios obtained from these variables in 42 hypertensive patients. Significantly lower values of HDL cholesterol, Apo-A and HDL-C/total cholesterol and Apo-A/Apo-B ratios were observed in smokers taking propranolol than non-smokers not taking propranolol. Smokers who were not on propranolol also had significantly lower values as compared to non-smokers. These findings suggest that smoking may be the more significant factor responsible for alteration in lipid profile.",
author = "Ananthakrishnan Ramani and Nayak, {Sudhakar S.} and Aroor, {A. R.} and Kundaje, {G. N.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1007/BF02864966",
language = "English",
volume = "6",
pages = "59--64",
journal = "Indian Journal of Clinical Biochemistry",
issn = "0970-1915",
publisher = "Springer India",
number = "1",

}

Effect of cigarette smoking on serum lipid, lipoprotein and apolipoprotein levels in hypertensives receiving β-adrenoreceptor blocking drugs. / Ramani, Ananthakrishnan; Nayak, Sudhakar S.; Aroor, A. R.; Kundaje, G. N.

In: Indian Journal of Clinical Biochemistry, Vol. 6, No. 1, 01.01.1991, p. 59-64.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of cigarette smoking on serum lipid, lipoprotein and apolipoprotein levels in hypertensives receiving β-adrenoreceptor blocking drugs

AU - Ramani, Ananthakrishnan

AU - Nayak, Sudhakar S.

AU - Aroor, A. R.

AU - Kundaje, G. N.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Both cigarette smoking and propranolol administration significantly alter plasma lipid profile. We examined the relationship of cigarette smoking and propranolol administration with fasting serum total cholesterol, triglyceride, lipoprotein cholesterol subfractions (high density, low density, and very low density), Apo-A, Apo-B and ratios obtained from these variables in 42 hypertensive patients. Significantly lower values of HDL cholesterol, Apo-A and HDL-C/total cholesterol and Apo-A/Apo-B ratios were observed in smokers taking propranolol than non-smokers not taking propranolol. Smokers who were not on propranolol also had significantly lower values as compared to non-smokers. These findings suggest that smoking may be the more significant factor responsible for alteration in lipid profile.

AB - Both cigarette smoking and propranolol administration significantly alter plasma lipid profile. We examined the relationship of cigarette smoking and propranolol administration with fasting serum total cholesterol, triglyceride, lipoprotein cholesterol subfractions (high density, low density, and very low density), Apo-A, Apo-B and ratios obtained from these variables in 42 hypertensive patients. Significantly lower values of HDL cholesterol, Apo-A and HDL-C/total cholesterol and Apo-A/Apo-B ratios were observed in smokers taking propranolol than non-smokers not taking propranolol. Smokers who were not on propranolol also had significantly lower values as compared to non-smokers. These findings suggest that smoking may be the more significant factor responsible for alteration in lipid profile.

UR - http://www.scopus.com/inward/record.url?scp=0025971452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025971452&partnerID=8YFLogxK

U2 - 10.1007/BF02864966

DO - 10.1007/BF02864966

M3 - Article

AN - SCOPUS:0025971452

VL - 6

SP - 59

EP - 64

JO - Indian Journal of Clinical Biochemistry

JF - Indian Journal of Clinical Biochemistry

SN - 0970-1915

IS - 1

ER -